Browsing by Author MERLO A.

Showing results 1 to 11 of 11
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2020JRC117906225Ac- and 213Bi-Substance P Analogues for Glioma TherapyKROLICKI LESZEK; KUNIKOWSKA JOLANTA; BRUCHERTSEIFER FRANK; KOZIARA H; KROLICKI B; JAKUCINSKI M; PAWLAK DARIUSZ; ROLA R; MORGENSTERN ALFRED; ROSIAK ELZBIETA, et alArticles in periodicals and books
2019JRC116487Improved tumor control and absence of late neurotoxicity using alpha (213Bi) as compared to beta (90Y) labelled-DOTA-Substance P for the treatment of low grade gliomasMERLO A.; KROLICKI LESZEK; CORDIER D.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFREDArticles in periodicals and books
2006JRC34219Local Trageting of Malignant Gliomas by the Difussible Peptidic Vector DOTAGA-substance PKNEIFEL S.; CORDIER D.; GOOD S.; IONESCU M.; GHAFFARI A.; HOFER S.; KRETSCHMAR M.; TOLNAY M.; APOSTOLIDIS CHRISTOS; WASER B, et alArticles in periodicals and books
2018JRC109738Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogueKROLICKI B; BRUCHERTSEIFER FRANK; KUNIKOWSKA JOLANTA; KOZIARA H; KROLICKI B; JAKUCINSKI M; PAWLAK DARIUSZ; APOSTOLIDIS CHRISTOS; MIRZADEH SAED; ROLA R, et alArticles in periodicals and books
2019JRC114146Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastomaKROLICKI LESZEK; BRUCHERTSEIFER FRANK; KUNIKOWSKA JOLANTA; KOZIARA H; KROLICKI B; JAKUCINSKI M; PAWLAK DARIUSZ; APOSTOLIDIS CHRISTOS; MIRZADEH SAED; ROLA R, et alArticles in periodicals and books
2019JRC116463Safety and therapeutic efficacy of 225Ac-DOTA-Substance P for therapy of brain tumorsKROLICKI LESZEK; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; KUNIKOWSKA JOLANTA; KOZIARA H; KROLICKI B; JAKUCINSKI M; PAWLAK DARIUSZ; APOSTOLIDIS CHRISTOS; ROLA R, et alArticles in periodicals and books
2018JRC107605Spät-Neurotoxizität der diffusiblen Beta-Radiopeptid-Brachytherapie im Vergleich zur AlphatherapieMERLO A.; CORDIER D.; FORRER F.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; MÄCKE H.Articles in periodicals and books
2017JRC106153Targeted alpha therapy of glioblastoma multiforme: clinical experience with 213Bi- and 225Ac-Substance PKROLICKI LESZEK; BRUCHERTSEIFER FRANK; KUNIKOWSKA JOLANTA; KOZIARA H; KROLICKI B; JAKUCINSKI M; PAWLAK DARIUSZ; APOSTOLIDIS CHRISTOS; ROLA R; MERLO A., et alArticles in periodicals and books
2019JRC118234Targeted alpha therapy of recurrent glia tumors : clinical experience with 225Ac-Substance-PKROLICKI LESZEK; BRUCHERTSEIFER FRANK; KUNIKOWSKA JOLANTA; KOZIARA H; KROLICKI B; JAKUCINSKI M; PAWLAK DARIUSZ; APOSTOLIDIS CHRISTOS; ROLA R; MERLO A., et alArticles in periodicals and books
2010JRC56637Targeted Alpha-Radionuclide Therapy of Functionally Critical Located Gliomas with 213Bismuth-DOTA-[Thi8,Met(O2)11]-Substance P - A Pilot TrialCORDIER D.; FORRER F.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; GOOD S.; MÜLLER-BRAND J.; MÄCKE H.; REUBI Jean-Claude; MERLO A.Articles in periodicals and books
2016JRC98415Targeted Radiolabeled Compounds in Glioma TherapyCORDIER D.; KROLICKI Leszek; MORGENSTERN Alfred; MERLO A.Articles in periodicals and books